My understanding is you choose to expense R&D in the first year and continue to expense those costs each year. I'm second guessing myself here as to if I should have expensed in the first year and perhaps capitalized and amortized. The company is a startup with no income so I'm looking a NOL carry forwards if I continue to expense. Capitalizing has better balance sheet presentation but if they do start showing income, there is no immediate writeoff.